Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAS Combined With Dexamethasone Versus Amisulpride for Preventing PONV After Laparoscopic Gynecological Surgery
NCT07631910Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Jul 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone and amisulpride in postoperative nausea and vomiting (PONV) (4 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: Postoperative Nausea and Vomiting Incidence at 48 hours and Postoperative Nausea and Vomiting Severity at 48 hours. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
dexamethasoneamisulpride
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT07631910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07631910.